Persistent itching can sometimes signal serious illness, including cancer. Oncologist Dr Amit Garg highlights four ...

A new drug application (NDA) has been submitted to the FDA seeking approval of rusfertide, an investigational hepcidin ...

Having itchy skin can be a sign of anything from irritating clothing to eczema, but an oncologist has warned that your ...

Jakavi® (ruxolitinib) approved by the European Commission for adult patients with polycythemia vera (PV) resistant to or intolerant of hydroxyurea PV is a rare blood cancer associated with an ...

Polycythemia vera is a classic myeloproliferative neoplasm and a chronic type of leukemia, which often leads to overproduction of various blood cells. In this interview, Andrew Kuykendall, MD, ...

TAMAQUA – Each time a discovery is made in the search for why an unusually large number of local residents are developing a rare form of cancer, it generates more questions than answers. There are no ...

Basel, March 7, 2014 - Novartis today announced that a pivotal Phase III trial of Jakavi ® (ruxolitinib) compared to best available therapy has met its primary endpoint of maintaining hematocrit ...

Persistent itchy skin is usually harmless, but doctors warn it can sometimes be linked to certain cancers. Here are four ...

The annual number of PV cases notified to the Swedish Cancer Registry has ranged from 90 to 170 with no evidence of a systematic trend. In the Family-Cancer Database the total number of affected ...

LIVER tumors, usually hepatomas, are relatively frequent in cases of hepatic cirrhosis, occurring in approximately 3 or 4 per cent of patients with alcoholic cirrhosis and in a somewhat higher ...

Rusfertide effectively maintained hematocrit control below 45% and reduced phlebotomy eligibility in PV patients through 52 ...